1. Anticoagulants for stroke prevention in heart failure with reduced ejection fraction

   • Andreas Schäfer
   • Ulrike Flierl
   • Johann Bauersachs

   Review Open access 27 August 2021 Pages: 1 - 13

   

2. Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials

   • Costanza Pellegrini
   • Erion Xhepa
   • Salvatore Cassese

   Original Paper Open access 23 December 2020 Pages: 14 - 22

   

3. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

   • Tze-Fan Chao
   • Yi-Hsin Chan
   • Shih-Ann Chen

   Original Paper 11 March 2021 Pages: 23 - 33

   

4. Large extracellular vesicles in the left atrial appendage in patients with atrial fibrillation—the missing link?

   • Andreas Zietzer
   • Baravan Al-Kassou
   • Felix Jansen

   Original Paper Open access 01 June 2021 Pages: 34 - 49

   

5. New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial

   • João Pedro Ferreira
   • John G. Cleland
   • Faiez Zannad

   Original Paper 14 June 2021 Pages: 50 - 59

   

6. Cardiac autonomic function and cognitive performance in patients with atrial fibrillation

   • Peter Hämmerle
   • Stefanie Aeschbacher
   • Christine S. Zuern

   Original Paper Open access 22 June 2021 Pages: 60 - 69

   

7. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

   • Marco Proietti
   • Marco Vitolo
   • the ESC-EHRA EORP-AF Long-Term General Registry Investigators

   Original Paper Open access 27 August 2021 Pages: 70 - 84

   

8. Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?

   • Miruna A. Popa
   • Marc Kottmaier
   • Felix Bourier

   Original Paper Open access 14 September 2021 Pages: 85 - 95

   

9. Immunothrombosis and new-onset atrial fibrillation in the general population: the Rotterdam Study

   • Martijn J. Tilly
   • Sven Geurts
   • Maryam Kavousi

   Original Paper Open access 24 September 2021 Pages: 96 - 104

   

10. Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs

    • Giuseppe D´Ancona
    • Erdal Safak
    • Hüseyin Ince

    Original Paper 15 October 2021 Pages: 105 - 113

    

11. Patients’ attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation

    • Tobias Uhe
    • Samira Beimel
    • Rolf Wachter

    Original Paper Open access 28 October 2021 Pages: 114 - 123